Trusted Resources: Education
Scientific literature and patient education texts
Developing a Treatment Plan for Sanfilippo Syndrome
source: Sanfilippo Syndrome News
year: 2021
summary/abstract:Sanfilippo syndrome is a neurodegenerative disorder that affects about one in 70,000 births. Because it’s rare, many physicians are unfamiliar with it and its treatment. This could pose a problem, especially in an emergency.
If your child has Sanfilippo syndrome, working with his or her primary care physician to develop and maintain a treatment plan can help ensure the best possible care.
Causes of Sanfilippo Syndrome
Sanfilippo syndrome is caused by mutations in genes that provide instructions necessary for cells to make essential metabolic enzymes. These mutations cause the enzymes not to function correctly. This causes sugar molecules called glycosaminoglycans to build up inside cells and tissues interfering with their function. With time, this can cause mental deterioration and mobility loss.
How Doctors Treat Sanfilippo Syndrome
There are currently no approved treatments that target the underlying cause of Sanfilippo syndrome. Treatment approaches focus on alleviating symptoms and improving patients’ quality of life. These involve collaboration among a multidisciplinary team of specialists.
read more
BookmarkRelated Content
-
A Guide to Understanding MPS IV (Morquio Syndrome)Mucopolysaccharidosis IV (MPS IV) is a r...
-
Advances in Approaches to Care and Monitoring of MPS Diseasehttps://www.youtube.com/watch?v=JZSVzeiX...
-
Sanfilippo Ideal for FDA’s Accelerated Approval Pathway, Foundation SaysThe Cure Sanfilippo Foundation is encour...
-
Significant Neuropsychiatric Symptoms: Three Mucopolysaccharidosis Type IIIB Cases, Two of Whom Were Siblings With a...Mucopolysaccharidosis (MPS) type IIIB pa...
-
The Beginning of the End of Allogeneic Transplantation for Hurler SyndromeHurler syndrome (mucopolysaccharidosis t...
-
A Multicenter Open-Label Extension Study of Intrathecal Heparan-N-Sulfatase in Patients With Sanfilippo Syndrome Typ...Sanfilippo syndrome type A (mucopolysacc...
-
AVROBIO Receives Rare Pediatric Disease Designation from the U.S. FDA for AVR-RD-05, a Gene Therapy for Mucopolysacc...AVROBIO, Inc., a leading clinical-stage ...
Powered by
